Details for Patent: 9,861,713
✉ Email this page to a colleague
Which drugs does patent 9,861,713 protect, and when does it expire?
Patent 9,861,713 protects PYLARIFY and is included in one NDA.
This patent has forty-six patent family members in twenty countries.
Summary for Patent: 9,861,713
| Title: | PSMA-binding agents and uses thereof |
| Abstract: | Prostate-specific membrane antigen (PSMA) binding compounds having radioisotope substituents are described, as well as chemical precursors thereof. Compounds include pyridine containing compounds, compounds having phenylhydrazine structures, and acylated lysine compounds. The compounds allow ready incorporation of radionuclides for single photon emission computed tomography (SPECT) and positron emission tomography (PET) for imaging, for example, prostate cancer cells and angiogenesis. |
| Inventor(s): | Pomper; Martin G. (Baltimore, MD), Mease; Ronnie Charles (Fairfax, VA), Chen; Ying (Lutherville-Timonium, MD) |
| Assignee: | THE JOHNS HOPKINS UNIVERSITY (Baltimore, MD) |
| Application Number: | 14/987,032 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Device; |
Drugs Protected by US Patent 9,861,713
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Progenics Pharms Inc | PYLARIFY | piflufolastat f-18 | SOLUTION;INTRAVENOUS | 214793-001 | May 26, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF POSITRON EMISSION TOMOGRAPHY (PET) IN MEN WITH PROSTATE CANCER | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,861,713
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009276423 | ⤷ Try a Trial | |||
| Canada | 2732632 | ⤷ Try a Trial | |||
| Canada | 2987744 | ⤷ Try a Trial | |||
| China | 102171187 | ⤷ Try a Trial | |||
| China | 107382846 | ⤷ Try a Trial | |||
| China | 113563262 | ⤷ Try a Trial | |||
| Cyprus | 1119367 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
